Search Results 2011-2020 of 19550 for autoimmune hepatitis
Nonalcoholic fatty liver disease, Cirrhosis, Hepatitis C, Hepatitis B, Portal hypertension, Alcoholic hepatitis, Hepato...cellular carcinoma, Hepatic ...
Liver disease or; Pancreas problems (eg, pancreatic insufficiency)—Use with caution. May increase risk for more serious side effects. Heart failure or ...
Infection, severe and active or · Liver disease (eg, cirrhosis, hepatitis B or C), untreated or uncontrolled, severe—Use is not recommended in patients with this ...
... autoimmune disorders OR c) PAH associated with: i ... Portopulmonary hypertension, portal hypertension, or chronic liver disease ... hepatitis B virus and/or ...
Hepatitis B, history of—Use with caution. May ... Liver disease, moderate to severe—Should not be ... For chronic hepatitis C virus infection, with or without ...
Liver disease (severe)—Patients with severe liver disease may have an increase in side effects. Stomach ulcer—Aminosalicylate sodium may cause stomach ...
A Mayo Clinic collaboration studies engineered stem cells for liver disease featured image. Research. A Mayo Clinic collaboration studies engineered stem ...
Inflammatory myopathies (dermatomyositis, anti-synthetase syndrome, myositis overlapping with other autoimmune diseases, HMGCR necrotizing myopathy) ...
Kidney disease and chronic liver disease. Mayo Clinic also heads the Nephrology Collaborative Group, a consortium of doctors who specialize in kidney ...
Resolution of NASH is defined as non-alcoholic fatty liver disease (NAFLD) activity score (NAS) of 0–1 for inflammation, 0 for ballooning, and any other value ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.